Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
16
GOVX Quote, Financials, Valuation and Earnings
Last price:
$0.39
Seasonality move
:
-3.87%
Day range:
$0.38 - $0.40
52-week range:
$0.37 - $2.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.66x
P/B ratio:
2.32x
Volume:
580.2K
Avg. volume:
529.1K
1-year change:
-82.95%
Market cap:
$11.4M
Revenue:
$4M
EPS (TTM):
-$1.89
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GOVX
GeoVax Labs, Inc.
|
-- | -- | -100% | -- | $9.63 |
|
DARE
Daré Bioscience, Inc.
|
-- | -$0.40 | 2911.81% | -13.48% | $10.75 |
|
JAGX
Jaguar Health, Inc.
|
$3.7M | -$5.08 | 20.18% | -92.94% | $25.50 |
|
OMER
Omeros Corp.
|
-- | -$0.48 | -- | -0.15% | $28.00 |
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
$2.3M | -$2.75 | -18.5% | -90.25% | $67.67 |
|
VTGN
Vistagen Therapeutics, Inc.
|
$145.8K | -$0.44 | -6.58% | -18.27% | $14.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GOVX
GeoVax Labs, Inc.
|
$0.38 | $9.63 | $11.4M | -- | $0.00 | 0% | 1.66x |
|
DARE
Daré Bioscience, Inc.
|
$1.79 | $10.75 | $25.6M | 95.38x | $0.00 | 0% | 361.34x |
|
JAGX
Jaguar Health, Inc.
|
$1.02 | $25.50 | $1.3M | -- | $0.00 | 0% | 0.08x |
|
OMER
Omeros Corp.
|
$10.62 | $28.00 | $753M | -- | $0.00 | 0% | -- |
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
$17.78 | $67.67 | $130.8M | -- | $0.00 | 0% | 9.58x |
|
VTGN
Vistagen Therapeutics, Inc.
|
$3.73 | $14.50 | $147.3M | -- | $0.00 | 0% | 130.92x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GOVX
GeoVax Labs, Inc.
|
-- | 1.075 | -- | 2.75x |
|
DARE
Daré Bioscience, Inc.
|
74.07% | 0.176 | 27.91% | 1.09x |
|
JAGX
Jaguar Health, Inc.
|
85.01% | -1.363 | 766.14% | 0.14x |
|
OMER
Omeros Corp.
|
254.22% | -1.203 | 126.5% | 0.76x |
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
0.18% | -3.103 | 0.24% | 9.28x |
|
VTGN
Vistagen Therapeutics, Inc.
|
2.73% | 0.724 | 1.35% | 5.66x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GOVX
GeoVax Labs, Inc.
|
-$16.8K | -$6.4M | -433.69% | -433.69% | -635.8% | -$6.2M |
|
DARE
Daré Bioscience, Inc.
|
-$610.6K | -$3.7M | -459.12% | -- | -159660.87% | -$616.8K |
|
JAGX
Jaguar Health, Inc.
|
$2M | -$7.2M | -97.4% | -524.57% | -234.77% | -$4.7M |
|
OMER
Omeros Corp.
|
-$240K | -$26.4M | -59.56% | -- | -- | -$18.5M |
|
TNXP
Tonix Pharmaceuticals Holding Corp.
|
$1.5M | -$33.1M | -61.13% | -62.54% | -1005.08% | -$31.5M |
|
VTGN
Vistagen Therapeutics, Inc.
|
$73K | -$20.1M | -74.76% | -76.57% | -7772.48% | -$13.8M |
GeoVax Labs, Inc. vs. Competitors
-
Which has Higher Returns GOVX or DARE?
Daré Bioscience, Inc. has a net margin of -630.04% compared to GeoVax Labs, Inc.'s net margin of -154904.35%. GeoVax Labs, Inc.'s return on equity of -433.69% beat Daré Bioscience, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M DAREDaré Bioscience, Inc.-26547.83% -$0.28 $11M -
What do Analysts Say About GOVX or DARE?
GeoVax Labs, Inc. has a consensus price target of $9.63, signalling upside risk potential of 2409.12%. On the other hand Daré Bioscience, Inc. has an analysts' consensus of $10.75 which suggests that it could grow by 500.56%. Given that GeoVax Labs, Inc. has higher upside potential than Daré Bioscience, Inc., analysts believe GeoVax Labs, Inc. is more attractive than Daré Bioscience, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GOVXGeoVax Labs, Inc.4 0 0 DAREDaré Bioscience, Inc.3 0 0 -
Is GOVX or DARE More Risky?
GeoVax Labs, Inc. has a beta of 3.638, which suggesting that the stock is 263.848% more volatile than S&P 500. In comparison Daré Bioscience, Inc. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.917%.
-
Which is a Better Dividend Stock GOVX or DARE?
GeoVax Labs, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Daré Bioscience, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeoVax Labs, Inc. pays -- of its earnings as a dividend. Daré Bioscience, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GOVX or DARE?
GeoVax Labs, Inc. quarterly revenues are --, which are smaller than Daré Bioscience, Inc. quarterly revenues of $2.3K. GeoVax Labs, Inc.'s net income of -$6.3M is lower than Daré Bioscience, Inc.'s net income of -$3.6M. Notably, GeoVax Labs, Inc.'s price-to-earnings ratio is -- while Daré Bioscience, Inc.'s PE ratio is 95.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeoVax Labs, Inc. is 1.66x versus 361.34x for Daré Bioscience, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GOVXGeoVax Labs, Inc.1.66x -- -- -$6.3M DAREDaré Bioscience, Inc.361.34x 95.38x $2.3K -$3.6M
-
Which has Higher Returns GOVX or JAGX?
Jaguar Health, Inc. has a net margin of -630.04% compared to GeoVax Labs, Inc.'s net margin of -312.94%. GeoVax Labs, Inc.'s return on equity of -433.69% beat Jaguar Health, Inc.'s return on equity of -524.57%.
Company Gross Margin Earnings Per Share Invested Capital GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M JAGXJaguar Health, Inc.64.58% -$6.28 $36.3M -
What do Analysts Say About GOVX or JAGX?
GeoVax Labs, Inc. has a consensus price target of $9.63, signalling upside risk potential of 2409.12%. On the other hand Jaguar Health, Inc. has an analysts' consensus of $25.50 which suggests that it could grow by 2400%. Given that GeoVax Labs, Inc. has higher upside potential than Jaguar Health, Inc., analysts believe GeoVax Labs, Inc. is more attractive than Jaguar Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GOVXGeoVax Labs, Inc.4 0 0 JAGXJaguar Health, Inc.1 0 0 -
Is GOVX or JAGX More Risky?
GeoVax Labs, Inc. has a beta of 3.638, which suggesting that the stock is 263.848% more volatile than S&P 500. In comparison Jaguar Health, Inc. has a beta of -0.122, suggesting its less volatile than the S&P 500 by 112.17%.
-
Which is a Better Dividend Stock GOVX or JAGX?
GeoVax Labs, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jaguar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeoVax Labs, Inc. pays -- of its earnings as a dividend. Jaguar Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GOVX or JAGX?
GeoVax Labs, Inc. quarterly revenues are --, which are smaller than Jaguar Health, Inc. quarterly revenues of $3.1M. GeoVax Labs, Inc.'s net income of -$6.3M is higher than Jaguar Health, Inc.'s net income of -$9.6M. Notably, GeoVax Labs, Inc.'s price-to-earnings ratio is -- while Jaguar Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeoVax Labs, Inc. is 1.66x versus 0.08x for Jaguar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GOVXGeoVax Labs, Inc.1.66x -- -- -$6.3M JAGXJaguar Health, Inc.0.08x -- $3.1M -$9.6M
-
Which has Higher Returns GOVX or OMER?
Omeros Corp. has a net margin of -630.04% compared to GeoVax Labs, Inc.'s net margin of --. GeoVax Labs, Inc.'s return on equity of -433.69% beat Omeros Corp.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M OMEROmeros Corp.-- -$0.47 $143M -
What do Analysts Say About GOVX or OMER?
GeoVax Labs, Inc. has a consensus price target of $9.63, signalling upside risk potential of 2409.12%. On the other hand Omeros Corp. has an analysts' consensus of $28.00 which suggests that it could grow by 163.65%. Given that GeoVax Labs, Inc. has higher upside potential than Omeros Corp., analysts believe GeoVax Labs, Inc. is more attractive than Omeros Corp..
Company Buy Ratings Hold Ratings Sell Ratings GOVXGeoVax Labs, Inc.4 0 0 OMEROmeros Corp.2 2 0 -
Is GOVX or OMER More Risky?
GeoVax Labs, Inc. has a beta of 3.638, which suggesting that the stock is 263.848% more volatile than S&P 500. In comparison Omeros Corp. has a beta of 2.485, suggesting its more volatile than the S&P 500 by 148.518%.
-
Which is a Better Dividend Stock GOVX or OMER?
GeoVax Labs, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Omeros Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeoVax Labs, Inc. pays -- of its earnings as a dividend. Omeros Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GOVX or OMER?
GeoVax Labs, Inc. quarterly revenues are --, which are smaller than Omeros Corp. quarterly revenues of --. GeoVax Labs, Inc.'s net income of -$6.3M is higher than Omeros Corp.'s net income of -$21.2M. Notably, GeoVax Labs, Inc.'s price-to-earnings ratio is -- while Omeros Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeoVax Labs, Inc. is 1.66x versus -- for Omeros Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GOVXGeoVax Labs, Inc.1.66x -- -- -$6.3M OMEROmeros Corp.-- -- -- -$21.2M
-
Which has Higher Returns GOVX or TNXP?
Tonix Pharmaceuticals Holding Corp. has a net margin of -630.04% compared to GeoVax Labs, Inc.'s net margin of -972.95%. GeoVax Labs, Inc.'s return on equity of -433.69% beat Tonix Pharmaceuticals Holding Corp.'s return on equity of -62.54%.
Company Gross Margin Earnings Per Share Invested Capital GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M TNXPTonix Pharmaceuticals Holding Corp.44.44% -$3.59 $231.6M -
What do Analysts Say About GOVX or TNXP?
GeoVax Labs, Inc. has a consensus price target of $9.63, signalling upside risk potential of 2409.12%. On the other hand Tonix Pharmaceuticals Holding Corp. has an analysts' consensus of $67.67 which suggests that it could grow by 280.58%. Given that GeoVax Labs, Inc. has higher upside potential than Tonix Pharmaceuticals Holding Corp., analysts believe GeoVax Labs, Inc. is more attractive than Tonix Pharmaceuticals Holding Corp..
Company Buy Ratings Hold Ratings Sell Ratings GOVXGeoVax Labs, Inc.4 0 0 TNXPTonix Pharmaceuticals Holding Corp.2 0 0 -
Is GOVX or TNXP More Risky?
GeoVax Labs, Inc. has a beta of 3.638, which suggesting that the stock is 263.848% more volatile than S&P 500. In comparison Tonix Pharmaceuticals Holding Corp. has a beta of 1.817, suggesting its more volatile than the S&P 500 by 81.674%.
-
Which is a Better Dividend Stock GOVX or TNXP?
GeoVax Labs, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tonix Pharmaceuticals Holding Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeoVax Labs, Inc. pays -- of its earnings as a dividend. Tonix Pharmaceuticals Holding Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GOVX or TNXP?
GeoVax Labs, Inc. quarterly revenues are --, which are smaller than Tonix Pharmaceuticals Holding Corp. quarterly revenues of $3.3M. GeoVax Labs, Inc.'s net income of -$6.3M is higher than Tonix Pharmaceuticals Holding Corp.'s net income of -$32M. Notably, GeoVax Labs, Inc.'s price-to-earnings ratio is -- while Tonix Pharmaceuticals Holding Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeoVax Labs, Inc. is 1.66x versus 9.58x for Tonix Pharmaceuticals Holding Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GOVXGeoVax Labs, Inc.1.66x -- -- -$6.3M TNXPTonix Pharmaceuticals Holding Corp.9.58x -- $3.3M -$32M
-
Which has Higher Returns GOVX or VTGN?
Vistagen Therapeutics, Inc. has a net margin of -630.04% compared to GeoVax Labs, Inc.'s net margin of -7525.97%. GeoVax Labs, Inc.'s return on equity of -433.69% beat Vistagen Therapeutics, Inc.'s return on equity of -76.57%.
Company Gross Margin Earnings Per Share Invested Capital GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M VTGNVistagen Therapeutics, Inc.28.3% -$0.54 $68.2M -
What do Analysts Say About GOVX or VTGN?
GeoVax Labs, Inc. has a consensus price target of $9.63, signalling upside risk potential of 2409.12%. On the other hand Vistagen Therapeutics, Inc. has an analysts' consensus of $14.50 which suggests that it could grow by 288.74%. Given that GeoVax Labs, Inc. has higher upside potential than Vistagen Therapeutics, Inc., analysts believe GeoVax Labs, Inc. is more attractive than Vistagen Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GOVXGeoVax Labs, Inc.4 0 0 VTGNVistagen Therapeutics, Inc.4 0 0 -
Is GOVX or VTGN More Risky?
GeoVax Labs, Inc. has a beta of 3.638, which suggesting that the stock is 263.848% more volatile than S&P 500. In comparison Vistagen Therapeutics, Inc. has a beta of 0.561, suggesting its less volatile than the S&P 500 by 43.86%.
-
Which is a Better Dividend Stock GOVX or VTGN?
GeoVax Labs, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vistagen Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeoVax Labs, Inc. pays -- of its earnings as a dividend. Vistagen Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GOVX or VTGN?
GeoVax Labs, Inc. quarterly revenues are --, which are smaller than Vistagen Therapeutics, Inc. quarterly revenues of $258K. GeoVax Labs, Inc.'s net income of -$6.3M is higher than Vistagen Therapeutics, Inc.'s net income of -$19.4M. Notably, GeoVax Labs, Inc.'s price-to-earnings ratio is -- while Vistagen Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeoVax Labs, Inc. is 1.66x versus 130.92x for Vistagen Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GOVXGeoVax Labs, Inc.1.66x -- -- -$6.3M VTGNVistagen Therapeutics, Inc.130.92x -- $258K -$19.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
39
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
